HB-002

N/A

Report date: 2023/12/18 18:08:35

Base Information

Drug NameHB-002
Drug Alias NameHB-002
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionTransforming growth factor beta 1 inhibitorsVascular endothelial growth factor inhibitors
TargetsTransforming growth factor beta 1Vascular endothelial growth factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHuaBo Biopharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHuaBo Biopharm Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A